MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism

Molecular Neurobiology

Volumn 53, Issue 1, 2016, Pages 40-56

  Kim, Ki Chan ^a,b   Choi, Chang Soon ^a,c   Kim, Ji Woon ^a,c   Han, Seol Heui ^a   Cheong, Jae Hoon ^d   Ryu, Jong Hoon ^e   Shin, Chan Young ^a,c  

^a Konkuk University   (South Korea)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Konkuk University School of Medicine   (South Korea)

^d Sahmyook University   (South Korea)

^e Kyung Hee University   (South Korea)

Author keywords

Autism spectrum disorders; Gender differences; Glutamatergic synapse; MeCP2; Valproic acid

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; METABOTROPIC RECEPTOR 5; METHYL CPG BINDING PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; SMALL INTERFERING RNA; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; FEMALE; GLUTAMATERGIC SYNAPSE; MALE; NEURAL STEM CELL; NONHUMAN; PERINATAL PERIOD; POSTSYNAPTIC DENSITY; PREFRONTAL CORTEX; PROGENY; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; SEXUAL DEVELOPMENT; SPRAGUE DAWLEY RAT; SYNAPSE;

ANIMALS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FEMALE; METHYL-CPG-BINDING PROTEIN 2; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SEX CHARACTERISTICS; SYNAPSES; VALPROIC ACID;

EID: 84953358604     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8987-z     Document Type: Article

References (92)

1. Zahn-Waxler C, Shirtcliff EA, Marceau K (2008) Disorders of childhood and adolescence: gender and psychopathology. Annu Rev Clin Psychol 4:275–303. doi:10.1146/annurev.clinpsy.3.022806.091358
2. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR (2011) Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatr 168(9):904–912. doi:10.1176/appi.ajp.2011.10101532
3. Gillberg C, Cederlund M, Lamberg K, Zeijlon L (2006) Brief report: “the autism epidemic”. The registered prevalence of autism in a Swedish urban area. J Autism Dev Disord 36(3):429–435. doi:10.1007/s10803-006-0081-6
4. Baron-Cohen S (2002) The extreme male brain theory of autism. Trends Cogn Sci 6(6):248–254
5. Baron-Cohen S (2010) Empathizing, systemizing, and the extreme male brain theory of autism. Prog Brain Res 186:167–175. doi:10.1016/B978-0-444-53630-3.00011-7
6. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R (2011) Why are autism spectrum conditions more prevalent in males? PLoS Biol 9(6):e1001081. doi:10.1371/journal.pbio.1001081
7. Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, Vishwanatha JK, Santella RM, Morabia A (2011) Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics Off J DNA Methylation Soc 6(5):623–629
8. Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA (2009) The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 4(8):e6767. doi:10.1371/journal.pone.0006767
9. Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ (2006) Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology 147(6):2909–2915. doi:10.1210/en.2005-1119
10. Nishijo M, Satarug S, Honda R, Tsuritani I, Aoshima K (2004) The gender differences in health effects of environmental cadmium exposure and potential mechanisms. Mol Cell Biochem 255(1–2):87–92
11. Kundakovic M, Gudsnuk K, Franks B, Madrid J, Miller RL, Perera FP, Champagne FA (2013) Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci U S A 110(24):9956–9961. doi:10.1073/pnas.1214056110
12. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185–188. doi:10.1038/13810
13. American Psychiatric Association A (2013) Diagnostic and statistical manual of mental disorders: (5th ed.). American Psychiatric Publishing
14. Rett A (1966) On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116(37):723–726
15. Hagberg B, Aicardi J, Dias K, Ramos O (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol 14(4):471–479. doi:10.1002/ana.410140412
16. Laurvick CL, de Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, Williamson S, Leonard H (2006) Rett syndrome in Australia: a review of the epidemiology. J Pediatr 148(3):347–352. doi:10.1016/j.jpeds.2005.10.037
17. Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics Off J DNA Methylation Soc 1(4):e1–e11
18. Zhang A, Shen CH, Ma SY, Ke Y, El Idrissi A (2009) Altered expression of autism-associated genes in the brain of Fragile X mouse model. Biochem Biophys Res Commun 379(4):920–923. doi:10.1016/j.bbrc.2008.12.172
19. Blue ME, Naidu S, Johnston MV (1999) Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 156(2):345–352. doi:10.1006/exnr.1999.7030
20. Blue ME, Naidu S, Johnston MV (1999) Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol 45(4):541–545
21. Blue ME, Kaufmann WE, Bressler J, Eyring C, O'Driscoll C, Naidu S, Johnston MV (2011) Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice. Anat Rec (Hoboken) 294(10):1624–1634. doi:10.1002/ar.21380
22. Kim KC, Lee DK, Go HS, Kim P, Choi CS, Kim JW, Jeon SJ, Song MR, Shin CY (2014) Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring. Mol Neurobiol 49(1):512–528. doi:10.1007/s12035-013-8535-2
23. LeBlanc JJ, Fagiolini M (2011) Autism: a “critical period” disorder? Neural Plast 2011:921680. doi:10.1155/2011/921680
24. Jian L, Nagarajan L, de Klerk N, Ravine D, Bower C, Anderson A, Williamson S, Christodoulou J, Leonard H (2006) Predictors of seizure onset in Rett syndrome. J Pediatr 149(4):542–547. doi:10.1016/j.jpeds.2006.06.015
25. Moser SJ, Weber P, Lutschg J (2007) Rett syndrome: clinical and electrophysiologic aspects. Pediatr Neurol 36(2):95–100. doi:10.1016/j.pediatrneurol.2006.10.003
26. Chao HT, Zoghbi HY, Rosenmund C (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56(1):58–65. doi:10.1016/j.neuron.2007.08.018
27. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468(7321):263–269. doi:10.1038/nature09582
28. D'Cruz JA, Wu C, Zahid T, El-Hayek Y, Zhang L, Eubanks JH (2010) Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice. Neurobiol Dis 38(1):8–16. doi:10.1016/j.nbd.2009.12.018
29. Calfa G, Hablitz JJ, Pozzo-Miller L (2011) Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J Neurophysiol 105(4):1768–1784. doi:10.1152/jn.00800.2010
30. Kim KC, Kim P, Go HS, Choi CS, Park JH, Kim HJ, Jeon SJ, Dela Pena IC, Han SH, Cheong JH, Ryu JH, Shin CY (2013) Male-specific alteration in excitatory postsynaptic development and social interaction in prenatal valproic acid exposure model of autism spectrum disorder. J Neurochem. doi:10.1111/jnc.12147
31. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes CC, Pierce K (2011) Neuron number and size in prefrontal cortex of children with autism. JAMA 306(18):2001–2010. doi:10.1001/jama.2011.1638
32. Zikopoulos B, Barbas H (2013) Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front Hum Neurosci 7:609. doi:10.3389/fnhum.2013.00609
33. Courchesne E, Pierce K (2005) Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr Opin Neurobiol 15(2):225–230. doi:10.1016/j.conb.2005.03.001
34. Rinaldi T, Perrodin C, Markram H (2008) Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front Neural Circ 2:4. doi:10.3389/neuro.04.004.2008
35. Go HS, Kim KC, Choi CS, Jeon SJ, Kwon KJ, Han SH, Lee J, Cheong JH, Ryu JH, Kim CH, Ko KH, Shin CY (2012) Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3beta/beta-catenin pathway. Neuropharmacology 63(6):1028–1041. doi:10.1016/j.neuropharm.2012.07.028
36. Yang Y, Raine A (2009) Prefrontal structural and functional brain imaging findings in antisocial, violent, and psychopathic individuals: a meta-analysis. Psychiatry Res 174(2):81–88. doi:10.1016/j.pscychresns.2009.03.012
37. Benoit BO, Savarese T, Joly M, Engstrom CM, Pang L, Reilly J, Recht LD, Ross AH, Quesenberry PJ (2001) Neurotrophin channeling of neural progenitor cell differentiation. J Neurobiol 46(4):265–280. doi:10.1002/1097-4695(200103)46:4<265::AID-NEU1007>3.0.CO;2-B
38. Conti L, Pollard SM, Gorba T, Reitano E, Toselli M, Biella G, Sun Y, Sanzone S, Ying QL, Cattaneo E, Smith A (2005) Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 3(9):e283. doi:10.1371/journal.pbio.0030283
39. Go HS, Shin CY, Lee SH, Jeon SJ, Kim KC, Choi CS, Ko KH (2009) Increased proliferation and gliogenesis of cultured rat neural progenitor cells by lipopolysaccharide-stimulated astrocytes. Neuroimmunomodulation 16(6):365–376. doi:10.1159/000228911
40. Levine E, Cupp AS, Skinner MK (2000) Role of neurotropins in rat embryonic testis morphogenesis (cord formation). Biol Reprod 62(1):132–142
41. Xing GG, Wang R, Yang B, Zhang D (2006) Postnatal switching of NMDA receptor subunits from NR2B to NR2A in rat facial motor neurons. Eur J Neurosci 24(11):2987–2992. doi:10.1111/j.1460-9568.2006.05188.x
42. Rinaldi T, Kulangara K, Antoniello K, Markram H (2007) Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci U S A 104(33):13501–13506. doi:10.1073/pnas.0704391104
43. Lopez-Bendito G, Shigemoto R, Fairen A, Lujan R (2002) Differential distribution of group I metabotropic glutamate receptors during rat cortical development. Cereb Cortex 12(6):625–638
44. Munoz A, Liu XB, Jones EG (1999) Development of metabotropic glutamate receptors from trigeminal nuclei to barrel cortex in postnatal mouse. J Comp Neurol 409(4):549–566. doi:10.1002/(SICI)1096-9861(19990712)409:4<549::AID-CNE3>3.0.CO;2-I
45. Nosyreva ED, Huber KM (2005) Developmental switch in synaptic mechanisms of hippocampal metabotropic glutamate receptor-dependent long-term depression. J Neurosci 25(11):2992–3001. doi:10.1523/JNEUROSCI. 3652-04.2005
46. Walcott EC, Higgins EA, Desai NS (2011) Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero. J Neurosci 31(37):13097–13109. doi:10.1523/JNEUROSCI. 1341-11.2011
47. Kumamaru E, Egashira Y, Takenaka R, Takamori S (2014) Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons. Neurosci Lett 569:142–147. doi:10.1016/j.neulet.2014.03.066
48. Moldrich RX, Leanage G, She D, Dolan-Evans E, Nelson M, Reza N, Reutens DC (2013) Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. Behav Brain Res 257:253–264. doi:10.1016/j.bbr.2013.09.049
49. Wang P, Zhang P, Huang J, Li M, Chen X (2013) Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function. Neurotoxicology 37:51–62. doi:10.1016/j.neuro.2013.03.007
50. Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Gottlicher M (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 22(13):3411–3420. doi:10.1093/emboj/cdg315
51. Chen WY, Weng JH, Huang CC, Chung BC (2007) Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1). Mol Cell Biol 27(20):7284–7290. doi:10.1128/MCB. 00476-07
52. Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J (2006) Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol 26(6):2019–2028. doi:10.1128/MCB. 26.6.2019-2028.2006
53. Liyanage VR, Zachariah RM, Rastegar M (2013) Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells. Mol Autism 4(1):46. doi:10.1186/2040-2392-4-46
54. Dong E, Guidotti A, Grayson DR, Costa E (2007) Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci U S A 104(11):4676–4681. doi:10.1073/pnas.0700529104
55. Milutinovic S, D'Alessio AC, Detich N, Szyf M (2007) Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 28(3):560–571. doi:10.1093/carcin/bgl167
56. Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, Sharma RP, Tremolizzo L, Tueting P (2011) Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60(7–8):1007–1016. doi:10.1016/j.neuropharm.2010.10.021
57. Asai T, Bundo M, Sugawara H, Sunaga F, Ueda J, Tanaka G, Ishigooka J, Kasai K, Kato T, Iwamoto K (2013) Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J Neuropsychopharmacol 16(10):2285–2294. doi:10.1017/S1461145713000710
58. Selker EU (1998) Trichostatin A causes selective loss of DNA methylation in Neurospora. Proc Natl Acad Sci U S A 95(16):9430–9435
59. Yang F, Zhang L, Li J, Huang J, Wen R, Ma L, Zhou D, Li L (2010) Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize. BMC Plant Biol 10:178. doi:10.1186/1471-2229-10-178
60. Palomero-Gallagher N, Bidmon HJ, Zilles K (2003) AMPA, kainate, and NMDA receptor densities in the hippocampus of untreated male rats and females in estrus and diestrus. J Comp Neurol 459(4):468–474. doi:10.1002/cne.10638
61. Damborsky JC, Winzer-Serhan UH (2012) Effects of sex and chronic neonatal nicotine treatment on Na(2)(+)/K(+)/Cl(-) co-transporter 1, K(+)/Cl(-) co-transporter 2, brain-derived neurotrophic factor, NMDA receptor subunit 2A and NMDA receptor subunit 2B mRNA expression in the postnatal rat hippocampus. Neuroscience 225:105–117. doi:10.1016/j.neuroscience.2012.09.002
62. Sato D, Lionel AC, Leblond CS, Prasad A, Pinto D, Walker S, O'Connor I, Russell C, Drmic IE, Hamdan FF, Michaud JL, Endris V, Roeth R, Delorme R, Huguet G, Leboyer M, Rastam M, Gillberg C, Lathrop M, Stavropoulos DJ, Anagnostou E, Weksberg R, Fombonne E, Zwaigenbaum L, Fernandez BA, Roberts W, Rappold GA, Marshall CR, Bourgeron T, Szatmari P, Scherer SW (2012) SHANK1 Deletions in males with autism spectrum disorder. Am J Hum Genet 90(5):879–887. doi:10.1016/j.ajhg.2012.03.017
63. Alonso-Nanclares L, Gonzalez-Soriano J, Rodriguez JR, DeFelipe J (2008) Gender differences in human cortical synaptic density. Proc Natl Acad Sci U S A 105(38):14615–14619. doi:10.1073/pnas.0803652105
64. Forlano PM, Woolley CS (2010) Quantitative analysis of pre- and postsynaptic sex differences in the nucleus accumbens. J Comp Neurol 518(8):1330–1348. doi:10.1002/cne.22279
65. Kurian JR, Forbes-Lorman RM, Auger AP (2007) Sex difference in mecp2 expression during a critical period of rat brain development. Epigenetics Off J DNA Methylation Soc 2(3):173–178
66. Aber KM, Nori P, MacDonald SM, Bibat G, Jarrar MH, Kaufmann WE (2003) Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions. Neuroscience 116(1):77–80
67. Maliszewska-Cyna E, Bawa D, Eubanks JH (2010) Diminished prevalence but preserved synaptic distribution of N-methyl-d-aspartate receptor subunits in the methyl CpG binding protein 2(MeCP2)-null mouse brain. Neuroscience 168(3):624–632. doi:10.1016/j.neuroscience.2010.03.065
68. Nguyen MV, Du F, Felice CA, Shan X, Nigam A, Mandel G, Robinson JK, Ballas N (2012) MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci 32(29):10021–10034. doi:10.1523/JNEUROSCI. 1316-12.2012
69. Durand S, Patrizi A, Quast KB, Hachigian L, Pavlyuk R, Saxena A, Carninci P, Hensch TK, Fagiolini M (2012) NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2. Neuron 76(6):1078–1090. doi:10.1016/j.neuron.2012.12.004
70. Blackman MP, Djukic B, Nelson SB, Turrigiano GG (2012) A critical and cell-autonomous role for MeCP2 in synaptic scaling up. J Neurosci 32(39):13529–13536. doi:10.1523/JNEUROSCI. 3077-12.2012
71. McGraw CM, Samaco RC, Zoghbi HY (2011) Adult neural function requires MeCP2. Science 333(6039):186. doi:10.1126/science.1206593
72. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320(5880):1224–1229. doi:10.1126/science.1153252
73. Zhang L, He J, Jugloff DG, Eubanks JH (2008) The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 18(3):294–309. doi:10.1002/hipo.20389
74. Weng SM, McLeod F, Bailey ME, Cobb SR (2011) Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal. Neuroscience 180:314–321. doi:10.1016/j.neuroscience.2011.01.061
75. Martin HG, Manzoni OJ (2014) Late onset deficits in synaptic plasticity in the valproic acid rat model of autism. Front Cell Neurosci 8:23. doi:10.3389/fncel.2014.00023
76. Maezawa I, Jin LW (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30(15):5346–5356. doi:10.1523/JNEUROSCI. 5966-09.2010
77. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374(6521):450–453. doi:10.1038/374450a0
78. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677–736. doi:10.1146/annurev.neuro.24.1.677
79. Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Hansen RL, Phillips TM (2001) Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 49(5):597–606
80. Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okado N, Narita M (2004) Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev 26(5):292–295. doi:10.1016/S0387-7604(03)00168-2
81. Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL (2001) Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatr 158(7):1058–1066
82. Li W, Pozzo-Miller L (2013) BDNF deregulation in Rett syndrome. Neuropharmacology. doi:10.1016/j.neuropharm.2013.03.024
83. Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH (2007) Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 10(12):1513–1514. doi:10.1038/nn2010
84. Chang Q, Khare G, Dani V, Nelson S, Jaenisch R (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49(3):341–348. doi:10.1016/j.neuron.2005.12.027
85. Yazdani M, Deogracias R, Guy J, Poot RA, Bird A, Barde YA (2012) Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 30(10):2128–2139. doi:10.1002/stem.1180
86. De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Van Criekinge W, De Backer GG, Gillebert TC, Van Oostveldt P, Bekaert S, Asklepios I (2007) Paternal age at birth is an important determinant of offspring telomere length. Hum Mol Genet 16(24):3097–3102. doi:10.1093/hmg/ddm271
87. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302(5646):885–889. doi:10.1126/science.1086446
88. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302(5646):890–893. doi:10.1126/science.1090842
89. Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, Hu L, Steen JA, Weitz CJ, Greenberg ME (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52(2):255–269. doi:10.1016/j.neuron.2006.09.037
90. Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J, Armstrong D, Paylor R, Zoghbi H (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35(2):243–254
91. De Filippis B, Ricceri L, Fuso A, Laviola G (2013) Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor/exploratory behaviour in a mouse model of Rett syndrome. Neuropharmacology 68:174–183. doi:10.1016/j.neuropharm.2012.05.048
92. Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy AK, Pozzo-Miller L (2009) Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis 34(2):199–211. doi:10.1016/j.nbd.2008.12.011